Is Aphria Inc. (TSX:APHA) a Buy Ahead of its Q2 Report?

Aphria Inc. (TSX:APHA)(NYSE:APHA) has bounced back following a December short report, but the company has been no stranger to controversy in the weeks since.

lush marijuana plants
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aphria (TSX:APHA)(NYSE:APHA) stock rose 5.82% on January 7. Shares have climbed 23% over the past month, but the stock is still down 47% over a three-month span. The stock plummeted to a 52-week low of $4.76 in early December after Aphria was targeted by a highly publicized short-seller report.

The Hindenburg Research report alleged that Aphria’s international acquisitions were largely bogus, calling into question its growth strategy heading into this year. Aphria quickly responded and stood behind its LATAM acquisitions in Columbia, Argentina, and Jamaica. Differing theories were rampant in the days following the report, and some speculated that the short report was part of a larger campaign in a bid to acquire Aphria for cheap.

Columbus-based Growth Brands announced a takeover bid for Aphria in late December that valued the company at $2.8 billion. The offer valued Aphria shares at $11 each, which, at the time, would have represented a 45.5% premium for shareholders. Growth Brands would later deny business links with Aphria. However, Aphria CEO Vic Neufeld reportedly had business dealings with the Schottenstein family, the principal investor of Xanthic Biopharma. Xanthic operates in the cannabis market as Green Growth.

The revelation of connections between the two companies has attracted some criticism, and Aphria has absorbed bad press in the past over its ethics when it came to its acquisition of Nuuvera. This gives investors something to think about, as Aphria prepares to release its second-quarter results on January 11.

This will be the first batch of results that will include post-legalization earnings. Aphria released its fiscal 2019 first-quarter results back on October 12. The company reported annual production capacity at Aphria One at 30,000 kilograms and 5,000 kilograms at Broken Coast. Demand for legal cannabis in Canada surged in the days following legalization, but supply has been a problem in the early going.

Aphria is well positioned to meet this demand in early 2019 and has secured supply agreements with every Canadian province and the Yukon territory.

Its international holdings were a huge draw for investors who were hoping for a positive run in 2019 and beyond. A recent BNN Bloomberg report hinted at some positives at its LATAM Jamaica location. The October-November harvest was reportedly the largest, and the farm has the capacity to increase its annual production to 16,000 kilograms. Quintessential Capital Management, which co-authored the report with Hindenburg Research, has continued to call the farm’s value into question.

Ultimately, these holdings represent a fraction of Aphria’s total assets. The company’s production capacity is projected to reach 255,000 kilograms annually this year. Aphria also boasts solid liquidity with over $300 million of cash on its balance sheet. Shares have bounced back following the short report and the “surprise offer” from Growth Brands, but investors should keep in mind that this fledgling industry is still small and interconnected.

Aphria does not boast the value it did immediately following the short report, but its domestic operations are tops in the young industry. The stock is still a speculative buy in the single digits ahead of its second-quarter earnings release.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »